Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020236
Company: GLAXOSMITHKLINE

• Other Important Information from FDA

Products on NDA 20236

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SEREVENT	SALMETEROL XINAFOATE	EQ 0.021MG BASE/INH	AEROSOL, METERED;INHALATION	Discontinued	None	No	No

Labels for NDA 020236

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
09/28/2004	SUPPL-30	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20236s030,20692s026lbl.pdf
08/11/2003	SUPPL-28	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20236slr028_serevent_lbl.pdf